1
Q
advantages of renal transplantation?
A
- removes burden of life long dialysis
- improves renal clearance - dialysis only provides GFR of around 10ml/min
- improves life expectancy
2
Q
+ of transplantation - renal clearance?
A
- improves renal clearance - dialysis only provides GFR of around 10ml/min
3
Q
disadvantages of renal transplantation?
A
- sig perioperative mortality risk - largely cardiovascular mortality or sepsis
- 2% of perioperative mortality
- new onset post transplant diabetes (NODAT) - 10-20%
- assoc w sig inc risk of graft loss and early death
4
Q
disadvantages of renal transplantation - immune related?
A
- lifelong burden of immunosuppression
- risk opportunistic infections - espec viral, pneumocystitis
- cancer risk - non-melanoma skin cancer, cervical, lymphoma
5
Q
absolute CI for renal transplants?
A
- active infections
- active cancer - wait 2-5 yrs following cure
- active drug misuse
- uncontrolled major psychiatric disease that would disrupt ability to take meds
- active non-concordance w treatment
- short life expectancy - under 5 yrs
6
Q
organ transplantation is governed by?
A
- Human Tissues Act 2004
- main change to prev legistlation - facilitated live donor transplantation between unrelated ppl
7
Q
Human tissues act 2004?
A
- regulates activities concerning the removal, storage, use and disposal of human tissue
- consent is the fundamental principle
8
Q
key points of the HTA?
A
- Reg storage, removal and use of human tissues
- makes it lawful to take minimum steps to preserve the organs of a deceased person for use in transplantation while steps are taken to determine the wishes of the deceased
9
Q
offences under the HTA?
A
- removing storring or using human tissue without consent
- storing or using donated tissue for a scheduled purpose for something else
- trafficiking in human tissue for transplant purposes
10
Q
types of transplants from cadaveric donors?
A
- heart beating - DBD
- non-heart beating - DCD
11
Q
heart beating (DBD) transplant?
A
- heart beating (DBD) - donation after brain death. Traditionally the more common one
12
Q
non heart beating donation?
A
- non-heart beating (DCD) - donation after cardiac death, organs no longer perfused at the time of transplantation
13
Q
main diff between heart beating and non heart beating transplants?
A
- main difference between DBD and DCD is that in DBD the kidneys are still perfused at the time of retrieval but aren’t in DCD
- With DCD youre more likely to get delayed graft function which means that the kidneys dont intially work on implantation
14
Q
changes in donation overtime?
A
- increase in donations from living donors over time up until 2014/2015 and then has tailed off - may be due to increased risk in end stage CKD in live donors
- DBD donors stayed the same
- DCD increased
15
Q
live donors?
A
- related - blood or emotional relation
- unrelated
- paired or pooled donor - organs exchanged between pairs to overcome incompatibility to obtain best immunological match
- altruistic donor - person donates to anyone
16
Q
how are live donations done?
A
- in paired or pooled transplants the organs are exchanged between donor-recepient pairs to overcome blood group or HLA incompatibility
17
Q
blood groups
A
18
Q
the independent assessor?
A
- All donors and organ recipients are required to see an Independent Assessor (lA) who is trained and accredited by the HTA.
- The lA interviews the donor and recipient both separately and together on our behalf and is independent of the healthcare teams who are involved with the medical parts of the process.
19
Q
independent assessor interviews?
A
- The purpose of the interviews is to ensure that donors are not forced to do something against their wishes, to ensure that no reward has been sought or offered and to ensure that the donor has the capacity to make an informed decision.
- Donors and recipients will be asked to bring along proof of their identity and proof of their relationship.
- It is a criminal offence to carry out a transplant operation between two living people if the conditions of the HT Act are not met.
20
Q
blood supply for the transplanted kidney?
A
- blood supply for the transplanted kidney is usually from the external iliac artery and vein usually, into the iliac fossa
- only the upper 1/3 of the ureter can be implanted when the kidney is transplanted bc its supplied by the renal artery
21
Q
types of organ rejection?
A
- hyperacute rejection: blood group incompatbility
- acute rejection or chronic rejection MHC antigens
22
Q
what is the MHC?
A
- genes coding for HLA, inherited
23
Q
Class 1 HLA?
A
- Class I antigens (HLA-A, B, Cw) - expressed on all nucleated cells
24
Q
Class II HLA?
A
- Class ll antigens (HLA-DR, DQ, DP) - expressed on antigen presenting cells, B lymphocytes and activated T cells
- can also be expressed on endothelial cells of BVs especially in the kidney
25
HLA and renal transplantation?
* as we have 2 copies of each HLA type, 6 different HLA antigens need to match (2 A, 2 B and 2 DR)
* If HLA types are all the same, there's a 0,0,0 mismatch
* if 1 A, 1 B and 2 DR are the same there is a 1,1,0 mismatch
* if none of the antigens are the same theres a 2,2,2 mismatch
26
Triggering an immune response in transplants?
* donor antigen is presented to recepient T cells by APCs - commonly dendtitis
* the APC may be of donor origin (direct) or recipient origin (indirect)
* antigen must be presented in association w a class 2 MHC w co-stim molecules in order to initate an immune response
27
what are the 3 signals in the immune response?
* -> T cell activation via recognition of the antigen by the CD3 receptor - signal 1
* -> associated w costimulatory molecule CD80,86 and CD28: signal 2
* -> T cells undergo IL-2 mediated clonal proliferation
* -> CD25 is the IL2 receptor - signal 3
* -> production of cytokines to recruit more inflammatory cells
28
summary of the 3 signals?
- signal 1: CD3
- signal 2: CD28, CD80
- signal 3: IL2, CD25
29
What are costim molcules?
CD40 and CD154
30
what are the calcineurin inhibitors?
Cyclosporin and tacrolimus:
31
axathioprine?
purine synthesis inhibitor
32
leflunomide?
pyridimine synthesis inhibitor
33
anti CD52?
alemtuzumab - depletes T cells
34
what is hyperacute rejection?
- Hyperacute rejection occurs when the recipient has pre-formed antibodies to the donor kidney (for example with a blood group incompatible transplant) - occurs immediately
35
36
what happens during hyperacute rejection?
* Antibody binds directly to antigens on the endothelium lining the capillaries of the kidney
* Complement activation and inflammatory cell infiltration result in endothelial damage
- Platelet adhesion and vascular thrombosis lead to renal infarction
37
hyperacute rejection is?
immediate
38
what is acute rejection?
* Antigen presentation leads to T cell activation
- Activated T cells undergo clonal proliferation and infiltrate tubules -> ATI -> cell death
* 'Helper' T cells recruit
- Cytotoxic T cells leading to direct cellular toxicity - Predominantly tubular rejection
- B cells leading to donor specific ab production - predom vascular rejection
39
what are the major causes of late graft loss?
* chronic rejection
* recurrent disease
* death w a functioning graft
40
what is the definition of kidney failure?
* reduction in kidney function
* usually identified from: decrease in urine output, increase in serum creatinine, decrease in eGFR
41
AKI =
sudden decrease in kidney function over days to weeks
42
CKD =
* CKD: there has been a persistent decline in kidney function over a longer time
43
Acute on C kidney failure
means that there has beena sudden decrease in kidney function in someone with chronic kidney disease
44
end stage kidney disease
End stage kidney disease means that there is insufficient kidney function to maintain life without renal replacement therapy
45
reversibility of kidney disease
* AKI or acute on chronic kidney disease -> potential to restore kidney function to normal (acute) or baseline abnormal (acute on chronic) function
46
stage 1 of CKD?
normal GFR
47
Stage 2 of CKD?
60-89 ml/ min
48
Stage 3 of CKD?
3a) 45-59 ml/min
3b 30-44 ml/min
49
Stage 4 of CKD?
15-29ml/min
50
stage 5 of CKD?
<15 ml/ min or RRT
51
RIFLE classification of CKD
52
Oliguria =
* Oliguria is an abnormally low urine output
* in adults <400mls/day or <0.5ml/kg body weight/hour)
53
anuria =
* Anuria is no urine output
* <50mls/day
54
Pre-renal injury?
* this implies decreased blood flow either because of a fixed obstruction (renal artery stenosis) or far more commonly a decreased circulating volume or blood pressure
55
site of intra-renal injury?
* This means that the injury is within the kidney itself
56
site of post-renal injury?
* This means that there is an obstruction somewhere between the
renal pelvis and the urethra - obstruction has to affect both kidneys to cause renal failure
57
causes of pre-renal failure - true hypovolaemia?
– History of volume loss
* GI – diarrhoea and/or vomiting diarrhoea and/or vomiting
* Burns
* Haemorrhage
58
causes of pre renal failure - relative hypovolaemia?
– Heart failure
– Septic shock
– Hepatorenal failure
59
Clues for pre-renal failure?
* cause for volume depletion
* signs of hypovolaemia - tachycardia, hypotension - espec postural hypotension
60
clues to renovascular disease?
- Atherosclerotic vascular disease elsewhere
* Hypertension
* Vascular bruits on abdominal examination
***** Deteriorating renal function with ACE-inhibition****
61
causes of intra-renal failure - glomerular?
Glomerulonephritis
62
tubular causes of intrarenal failure?
* Ischaemic ATN (prolonged pre‐renal/contrast nephropathy)
* Nephrotoxic ATN (gentamicin/amphotericin/paracetamol)
* Intratubular obstruction (crystals/myoglobin/myeloma)
63
intersitial causes of tubular renal failure?
– Acute pyelonephritis
– Acute interstitial nephritis (drugs/infection)
64
vascular causes of intra-renal failure?
* Vasomotor (drugs including NSAID’s/ACE‐I’s)
* Malignant hypertension, scleroderma
* Vasculitis
* Microvascular obstruction (atheroemboli/cholesterol emboli/HUS/ TTP)
65
volume depletion and ACE
66
NSAIDs
67
features suggestive of intra-renal AKI?
- proteinuria - suggestive of glomerular disease
- haematuria
68
proteinuria - microalbuminuria?
* Microalbuminuria (measured by an albumin:creatine ratio) is an indicator of early diabetic nephropathy and capillary injury indicator of early diabetic nephropathy and capillary injury secondary to hypertension or vascular disease
* The urine dipstick test will be negative
69
proteinuria ?
* Proteinuria (measured by a protein:creatinine ratio) is an indicator of glomerular disease (glomerulonephritis)
* The urine dipstick test will be positive
70
visible haematuria?
* visible (macroscopic) - more commonly indicates bleeding within the urinary tract
71
invisible haematuria?
* invisible - more commonly indicates glomerular haematuria
72
post-renal renal failure - in order to cause renal failure?
* in order to cause renal failure, the obstruction needs to be bilateral or affect a single functioning kidney e.g. kidney transplants
73
sites of obstruction - PUJ?
- Bilateral pelvicoureteric junction (PUJ)
* Bilateral ureteric - tumour /retroperitoneal fibrosis / bilateral stones / bilateral sloughed papilla
74
Sites of obstruction - bladder outflow?
- Prostatic hypertrophy / stone / tumour / neurogenic bladder
75
sites of obst- urethra?
- Tumour / valves / stricture/ foreign body
76
clues to obstructive picture
history of:
- urinary tract surgery
- pelvic malignancy/radiotherapy - bladder symptoms
- polyuria (early obstruction)
- anuria (very late obstruction
77
clues to obstructive picture:
Signs of
- palpable bladder - prostatic enlargement
- abnormal rectal or vaginal examination
78
absence of ? makes obstruction unlikely
hydronephrosis on renal US
79
roles of the normal kidney
80
signs and symptoms of uraemia
81
Treatment of severe renal failure?
* dialysis
* transplantration
* conservative care of ESRF - symptom management
82
cautions of ACE/ ARB
* hyperkalaemia
* fall in GFR
* renal artery stenosis
* volume depletion
83
Tx of water/ sodium retention?
* dietary salt restriction
* loop diuretic
84
anemia?
* less EPO -> anaemia
* treat w recombinant EPO if sympptomatic
* target hb: 100-120
* avoid overcorrection - risk of excess cardiovascular mortality
85
pathophys of sodium retention?
86
consequences of severe hyperkalaemia?
* can cause cardiac arrest
87
Pathophys of bone disease
88
pathophys of acidosis and hyperkalaemia
89
Staging of CKD
* Stage 1: Normal GFR; GFR >90 mL/min/1.73 m2 with other evidence of chronic kidney damage
* Stage 2: Mild impairment; GFR 60-89 mL/min/1.73 m2 with other evidence of chronic kidney damage
* Stage 3: Moderate impairment; GFR 30-59 mL/min/1.73 m2
* Stage 3 CKD should be split into two subcategories defined by (2):
* GFR 45-59 ml/min/1.73 m2 (stage 3A)
* GFR 30-44 ml/min/1.73 m2 (stage 3B)
* Stage 4: Severe impairment: GFR 15-29 mL/min/1.73 m2
* Stage 5: Established renal failure (ERF): GFR < 15 mL/min/1.73 m2 or on dialysis
90
other evidence of chronic kidney damage may be one of the following:?
* persistent microalbuminuria
* persistent proteinuria
* persistent haematuria (after exclusion of other causes, e.g. urological disease)
* structural abnormalities of the kidneys demonstrated on ultrasound scanning or other radiological tests, e.g. polycystic kidney disease, reflux nephropathy
* biopsy-proven chronic glomerulonephritis (most of these patients will have microalbumuria or proteinuria, and/or haematuria)
91
The definition of CKD is the presence of either of the following for 3 months (i.e. chronicity) or more:
* Marker of kidney damage:
* Albuminuria (> 3 mg/mmol, i.e. A2/3)
* Abnormalities (including electrolyte derangement) secondary to tubular disorders
* Structural abnormalities
* Abnormalities on histology
* History of kidney transplant
* Reduced GFR: GFR < 60 ml/min/1.73 m2 (i.e. G3a-G5)
92
CF of CKD?
* patients generally asymptomatic but develop non specific symptoms at more advanced stages - GFR under 45
93
symptoms of CKD?
* Frequently asymptomatic in early stages
* Anorexia & nausea
* Fatigue & weakness
* Muscle cramps
* Pruritus
* Dyspnoea
* Oedema
94
Signs of ckd?
* Pallor (secondary to anaemia)
* Hypertension
* Skin pigmentation
* Excoriation marks
* Peripheral neuropathy
95
signs of overload with CKD?
(e.g. raised JVP, peripheral & pulmonary oedema)
96
uraemic encephalopathy?
* in severe renal impairment patients can develop high urea levels -> uraemic encephalopathy - seizures, confusion, low consciousness
97
other things that can arise from CKD?
* pericarditis (e.g. pericardial effusion and clinical rub on auscultation)
* and defective platelet function (causes bruising)
98
Diagnosis of CKD?
* serum creatine and urinary ACR
* Serum creatinine levels have a high individual variation changing with disease states, muscle mass, pregnancy and dietary intake.
99
investigations for CKD?
* urine dipstick
* urine microscopy
* ACR - spot test or 24 hr collection
* electrophoresis (e.g. myeloma)
100
Screening for CKD?
* FBC, U&Es, PTH, myeloma screen
101
imaging for CKD
* renal US
* MR angiography
* echo
* ECG - high risk of CVS disease
102
Management of CKD involves?
* blood pressure control and reducing proteinuria
* standard target - >140/90 for CDK
103
when is there a lower target for BP w CKD?
f the ACR is > 70 mg/mmol then a tigher blood pressure control may be targeted (< 130/80 mmHg).
104
How is HTN with proteinuria on a history oc CKD managed?
* ACE/ ARB for CKD hypertension with proteinuria
105
SGLT2 inhibitor?
* dapaglflozin
* decreases renal intraglomerular pressure and inhibiting RAAS
106
other therapies for CKD?
* statins
* smoking cessation
* antiplatelets for secondary prevention of CVS disease
107
108
complications of CKD - potassium
* hyperkalaemia - NSAIDs and potassium-sparing diuretics, may worsen hyperkalaemia
* Acute rises in potassium should be managed as a medical emergency.
108
Complications of CKD - anemia?
* anemia - A normocytic normochromic anaemia is typical of CKD.
* treated using erythropoietin-stimulating agents (ESA) such as epoetin alfa.
109
management of acute hyperkalaemia?
* This involves stabilisation of the myocardium (with calcium gluconate) and
* driving potassium into the intracellular compartment (with insulin/dextrose).
110
management of chronic hyperkalamia?
* Chronic elevations in serum potassium can be managed with low potassium diets, potassium-binding resins and correction of acidosis.
111
electrolyte abn associated w reduced kidney function?
* In disease, reduced kidney function (usually associated with a GFR < 30ml/min) leads to hypocalcaemia, hyperphosphataemia and hyperparathyroidism (secondary hyperparathyroidism
* can lead to osteomalacia, osteoporosis and osteitis fibrosa cystica - renal osteodystophy
112
management of hypocalccaemia?
dietary supplements and calcitriol
113
113
management of hyperphosphateaemia?
* Hyperphosphataemia: dietary restriction and phosphate binders (e.g. calcium acetate).
114
management of hyperparathyroidism?
* Hyperparathyroidism: calcimimetics or surgery.
115
complications - fluid overload?
* hypervolaemia and patients may have evidence of peripheral oedema, ascites, raised JVP, gallop rhythm and bilateral pleural effusions.
115
management of fluid overload?
* Fluid overload can be managed with a combination of fluid restriction, reduced sodium intake and the use of oral diuretics (e.g. furosemide).
116
metabolic ? with CKD?
* tendency to retain H+, acidosis can exacerbate hyperkalaemia
117
Renal replacement therapies?
- haemodialysis
- peritoneal dialysis
- renal transplantation
118
118
118
119
haemodialysis involves?
* Haemodialysis involves the removal of waste products and other substances by passing blood through a dialysis machine.
* Blood comes into contact with a semi-permeable membrane, which contains the dialysate on the other side.
* Substances may then diffuse between the two fluids (blood and dialysate).
120
what does haemodialysis require?
* Haemodialysis requires intravenous access in the form of an arteriovenous fistula or an artificial line (e.g. portacath).
- Patients usually have haemodialysis 3-4 times a week for several hours.
121
peritoneal dialysis?
* Peritoneal dialysis is achieved by using the peritoneal cavity as the primary site of ultrafiltration.
* A catheter (e.g. Tenckhoff catheter) is inserted into the abdominal cavity, which allows the infusion of the dialysate.
* The dialysate then dwells within the abdomen using the peritoneum as a semi-permeable membrane for the transfer of waste products.
* The dialysate can then be removed after a certain amount of time and the procedure repeated.
122
Ways in which peritoneal diaysis can be carried out?
* In general, peritoneal dialysis can be achieved by continuous ambulatory peritoneal dialysis (CAPD) where multiple exchanges are made each day, or by automated peritoneal dialysis (APD) where the exchange is made overnight when the patient sleeps.
123
Renal transplantation is the?
gold standard for RRT
124
Complications of transplantation?
* complications: graft rejection, complications from immunosuppressive agents (e.g. malignancy, infection) and disease recurrence.
125
Obstructive uropathy?
* obstructive uropathy is a disorder of the urinary tract which occurs due to obstructured urinary flow and can be either structural or functional
* back up of urine causes hydronephrosis
126
most common cause of obs uropathy?~
BPH
127
other causes of obst uropathy?
constipation, urethral stricture, colonic endometriosis, parasitic obstructions, prostatic adenocarcinoma
128
who does obst uropathy affect more?
* obstructive uropathy is more common in men in their 60s
* Obstructive uropathy is significantly less common in females.
129
symptoms of BPH?
* Nocturia, dysuria, urinary urgency or frequency, and decreased force of urinary stream should suggest benign prostatic hypertrophy/hyperplasia or prostatic adenocarcinoma.
130
Fever + BPH symptoms?
* Fever should increase your concern for concomitant urinary tract infection and, possibly, septicemia.
131
prostatic malignancy should be considered when?
* Prostatic malignancy should be considered in the presence of recent unintentional weight loss, night sweats, and hematuria with a nodular prostate on examination.
132
what can cause scarring -> obs uropathy?
* Radiation and other treatments for prior malignancies can increase scarring in the GU tract and produce obstruction.
133
GI features that can contribute to obst uropathy?
* Gastrointestinal symptoms of constipation, nausea, vomiting, and diarrhea may aid in diagnosing fecal impaction, bowel obstruction, or a colonic mass as contributing factors to the urinary tract obstructions.
134
obst uropathy: what can suggest uretral injury?
* Recent surgeries (e.g., appendectomy, hysterectomy) can suggest ureteral injury
135
An upper urinary tract obstruction (i.e. in the ureters) presents with:
* Loin to groin or flank pain on the affected side (due to stretching and irritation of ureter and kidney)
* Reduced or no urine output
* Non-specific systemic symptoms, such as vomiting
* Impaired renal function on blood tests (i.e. raised creatinine)
136
Lower urinary tract obstruction (i.e. in the bladder or urethra) presents with:
* Difficulty or inability to pass urine (e.g., poor flow, difficulty initiating urination or terminal dribbling)
* Urinary retention, with an increasingly full bladder
* Impaired renal function on blood tests (i.e. raised creatinine)
137
Common causes of UT obstruction?
* Kidney stones
* Tumours pressing on the ureters
* Ureter strictures (due to scar tissue narrowing the tube)
* Retroperitoneal fibrosis (the development of scar tissue in the retroperitoneal space)
* Bladder cancer (blocking the ureteral openings to the bladder)
* Ureterocele
138
ureterocele?
(ballooning of the most distal portion of the ureter – this is usually congenital)
139
common causes of LUT obstruction?
* Benign prostatic hyperplasia (benign enlarged prostate)
* Prostate cancer
* Bladder cancer (blocking the neck of the bladder)
* Urethral strictures (due to scar tissue)
* Neurogenic bladder
140
Management of a urinary obstr?
* nephrostomy: to bypass an obstruction in the upper UT e.g. a ureteral stone
* A nephrostomy involves surgically inserting a thin tube through the skin at the back, through the kidney and into the ureter.
* This tube allows urine to drain out of the body, into a bag.
141
How can an obstruction in the lower UT be bypassed?
* A urethral or suprapubic catheter may be used to bypass an obstruction in the lower urinary tract (e.g., a urethral stricture or prostatic hyperplasia).
* A urethral catheter is a tube, inserted through the urethra, into the bladder.
* A suprapubic catheter is a tube, inserted through the skin just above the pubic bone, directly into the bladder.
142
Hydronephrosis?
* due to obstruction of the urinary tract leading to back pressure into the kidneys
* Idiopathic hydronephrosis is the result of a narrowing at the pelviureteric junction
* can be congenital or develop later
143
features of hydronephrosis?
* Typical presenting features of hydronephrosis are vague renal angle pain and a mass in the kidney area.
* It may be seen on an ultrasound, CT scan or intravenous urogram (x-ray with IV contrast collecting in the urinary tract).
144
Ix of obst uropathy?
* urinalaysis - infection, haematuria
* creatinine
* FBC - anemia, sepsis
* prostate specific antigen - BPH, prostate cancer
145
BPH is caused by?
* Affects men over 50
* It is caused by hyperplasia of the stromal and epithelial cells of the prostate.
* It usually presents with lower urinary tract symptoms.
146
in BPH proliferation occurs in the?
* proliferation occurs primarily in the transition zone of the prostate, this leads to restriction of the prostatic urethra and urinary flow.
147
What are the LUTS?
* Hesitancy – difficult starting and maintaining the flow of urine
* Weak flow
* Urgency – a sudden pressing urge to pass urine
* Frequency – needing to pass urine often, usually with small amounts
* Intermittency – flow that starts, stops and varies in rate
* Straining to pass urine
* Terminal dribbling
* Incomplete emptying
* Nocturia
148
scoring system for severity of LUT symptoms
The international prostate symptom score (IPSS) is a scoring system that can be used to assess the severity of lower urinary tract symptoms.
149
assessment of BPH?
* digital rectal examination
* abd examination - palpable bladder
* PSA
* urine dipstick
* urinary frequency volume chart
150
PSA -?
* high false positive rate
151
Common causes of a raised PSA?
* Prostate cancer
* Benign prostatic hyperplasia
* Prostatitis
* Urinary tract infections
* Vigorous exercise (notably cycling)
* Recent ejaculation or prostate stimulation
152
what does a benign prostate feel like?
* A benign prostate feels smooth, symmetrical and slightly soft, with a maintained central sulcus
153
what does a cancerous prostate feel like?
* A cancerous prostate may feel firm/hard, asymmetrical, craggy or irregular, with loss of the central sulcus
154
management of BPH - 2 drug classes?
- alpha blockers
- 5 alpha reductase inhibitors
155
alpha blockers?
* Alpha-blockers (e.g., tamsulosin) relax smooth muscle, with rapid improvement in symptoms
156
5-alpha reductase inhibitors ?
(e.g., finasteride) gradually reduce the size of the prostate by blocking DHT production
157
Ix of BPH?
* dipstick
* bloods - FBC, UEs, LFTs - ALP may be elevated in prostatic cancer w bony mets
158
imaging for BPH?
* USS - size of prostate and evaluate for hydronephrosis
* MRI prostate - diagnosis of malignancy
159
physical side effects of haemodialysis?
* hypotension - one of the most common
* nausea and dizziness
* sepsis
* muscle cramps - usually in the lower le
* itchy skin
* loss of libido and erectile dysfunction
160
psychological side effects of haemodialysis?
* mental fatigue
* drowsiness
* tiredness
* light headedness
* lack of motivation
161
impacts of haemodialysis on social wellbeing?
* low self esteem
* loneliness
* depression
* anxiety
* repeated hospital trips - impact on work and social life
162
concern w peritoneal dialysis?
peritonitis
163
signs of peritonitis?
* abdominal pain
* a high temperature
* feeling and being sick
* experiencing chills
* the used dialysis fluid becoming cloudy
164
other risks of peritoneal dialysis?
* hernia - inc strain on the abdominal muscles
* weight gain
165
psychological issues of peritoneal dialysis?
* depression
* loss of sexual function -> relationship issues
* family burden
* loss of independence
166
which type of immunity are B cells involved?
* humoral/ antibody mediated immunity - activated by TH2 cells
* fights extracellular infections, including most bacteria and fungi, protozoans such as Giardia, and parasitic worms such as Schistosoma.
167
types of B cells?
* plasma cells
* memory B cells
168
IgM?
* IgM – this has a pentameric structure.
* It is expressed on B cell surfaces and produced early in the immune response whilst IgG is being generated.
169
IgG?
* Monomeric structure
- It is found mainly in circulating blood and tissues
- it also crosses the placenta to provide passive immunity to the fetus
170
IgA?
* forms a dimeric structure once it reaches its target tissues.
- It is found in mucosal areas such as the GI, respiratory and urinary tracts.
- It is also secreted in saliva, tears and breast milk.
171
IgE?
* IgE – this has a monomeric structure
- It binds to allergens and mediates allergic reactions, as well as providing immunity against multicellular organisms such as parasitic worms.
172
IgD?
* IgD – this has a monomeric structure and is rather mysterious.
* It is found in very low levels in the serum, and appears to interact with basophils and mast cell
173
all T cells express?
* all T cells express CD3 on their surfaces, along with T cell receptors (TCRs) which recognise specific antigens presented in an MHC I or MHC II molecule
174
Helper T cells?
* helper T cells (CD4) facilitate the activation of the immune response and stimulate division and differentiation of various effector cells
175
cytotoxic T cells?
* cytotoxic T cells (CD8) – also known as killer or effector T cells – provide cell-mediated immunity by targeting and killing infected cells
176
regulatory T cells ?
* regulatory T cells (CD25 + FOXP3) – also known as suppressor T cells – play a vital role in limiting the immune response to prevent excessive damage to tissues and organs
177
memory t cells?
* memory T cells (CD62 + CCR7) “remember” what has happened to allow the immune system to mount a faster, more effective response
178
How is cell mediated immune response activated?
* activated by TH1 -> activation of APC and cytotxic T cells
* designed to fight intracellular infections, including viruses, some bacteria and fungi, and protozoans such as Plasmodium and Toxoplasma.
179
steps of T cell development?
* T cells undergo education in the thymus gland
* tested with self cell antigens
* any cells which have generated a receptor that reacts to these undergo negative selection and are destroyed
* this prevents the immune system from reacting to the body and is known as immunological tolerance or self tolerance
180
T cells - graduation from the thymus?
* In order to graduate successfully from the thymus, T cells must also express CD3 and CD4 or CD8 (but never both), and bind to self MHC
complexes (but not too strongly?
181
steps of the cell mediated resp?
* First step of the cell mediated response is the activation of APCs
* TH1 cell encounters an infected APC and recognises the MHC-2 restricted antigen on its surface
* this activates the APC by providing a CD40 ligand second signal and secreting interferon-gamma (IFNγ)
182
2: once activated, APCs are able to increase production of?
* increase their production of nitric oxide and superoxide radicals,
* which optimises their killing mechanisms and allows them to destroy ingested pathogens much more effectively
183
3: cytoxic T cell response?
* next step is the activation of antigen specific cytotoxic T cell response
* activated APCs present their antigen to the specific cytotoxic T cell receptor within an MHC I, along with a variety of second signals, including B7 + CD28 and/or 4-IBB + 4-IBBL
184
APC presentation to cytotoxic T cells is helped by?
* this process is helped along by the secretion of IL-2 – a potent T cell growth factor – by TH1 cells and the cytotoxic T cells themselves
185
how do activated CT cells recognise infected cells?
* activated cytotoxic T cells recognise infected cells by recognising the MHC1 presenetd antigen
186
how do T cells damage cells?
* T cells secrete perforin to create holes in the cell wall
* They then use this hole to release granzymes and granulysin into the cell, which induce apoptosis and DNA fragmentation.
* Fas ligand interactions between the cell surfaces can also produce apoptosis of the infected cells via the aptly named death-inducing signalling complex (DISC)
187
T cells can also release?
- interferon gamma
- is able to block intracellular viral replication without killing the cell itself
188
Memory T cells?
* after the infection subsides, most antigen specific cytotoxic T cells will remain as dormant memory T cells
* during reinfection, only the first signal (MHC + antigen) is required to activate the cytotoxic T cell response; no second signal is necessary
* this means that any antigen- presenting cell (not just dendritic cells) can activate cytotoxic T cells directly, reducing the need for TH1 cell help and resulting in a much swifter and more efficient cell- mediated immune response.
189
extracellular infections –>
TH2 –> humoral immune response with B cells and antibodies
190
intracellular infections –>
TH1 –> cell- mediated immune response with activated APCs and cytotoxic T cells
191
blood group A?
has A antigens on the red blood cells with anti-B antibodies in the plasma
192
blood group B?
has B antigens with anti-A antibodies in the plasma
193
gr O?
has no antigens, but both anti-A and anti-B antibodies in the plasma
194
gr AB?
has both A and B antigens, but no antibodies
\
195
Group A genotype?
* Group A: can be IAIA or IAi genotypes
196
Group B genotype?
* Group B: can be IBIB or IBi genotypes
197
Group AB genotype?
* Group AB: can only be IAIB genotype
198
group O genotype?
* Group O: can only be ii genotype
199
which alleles are codominant?
* A and B alleles are codominant but O is recessive
200
Universal donor and universal recipent?
* O is the universal donor
* AB is the universal recipient
201
which blood can safely given in emergencies?
* O Rh - blood can be safely given to anyone
* used in emergencies
202
All blood donations are routinely tested for?
* All donations are routinely tested for hepatitis B, hepatitis C, hepatitis E, human immunodeficiency virus, syphilis and for first time donors, human T-lymphotropic virus,
203
Blood transfusion w ? is the best practice?
identical ABO and rh
204
group and hold test?
* Screening for antibodies is part of the standard group and hold pathology test (also known as a type and screen).
- Any subsequent crossmatch involves testing the units to ensure there is no clinically detectable agglutination reaction between the patient’s blood sample and the blood product to be crossmatched.
205
haemolytic transfusion reaction?
* Transfusion of an incompatible blood product can cause a haemolytic transfusion reaction, where the antibody-antigen reaction causes the affected cells to be destroyed. This haemolysis could be either intravascular or extravascular, depending on whether the classical complement pathway is activated.
206
Matching?
* kidney donor and recepients are matched by blood group and tissue type
* people from the same ethnic background are more likely to have matching blood groups and tissue types.
207
HLA typing?
* blood test to determine the HLA type of the patient and the potential donor to see how well they matc
* 6 antigen match is the best but is very rare to get, especially if they are unrelated - zero mismatch
* second blood test is to measure antibodies to HLA - done for the patient only
208
Serum crossmatch?
* donor cells mixed w patients serum
* If your serum has antibodies against the donor's cells, the antibodies will bind the donor cells and be detected using a fluorescent detection method.
* If these antibodies are at high levels, the donor cells will be destroyed.
* This is called a positive crossmatch and it means that the transplant cannot take place.
209
five ab classes image
210
role of the HTA 2004?
* regulates activities concerning the removal, storage, use and disposal of human tissue
* The Human Tissue Act 2004 also created an offence of DNA ‘theft’.
* It is unlawful to have human tissue with the intention of its DNA being analysed, without the consent of the person from whom the tissue came
211
Offences under the HTA
1) Removing, storing or using human tissue for Scheduled Purposes without appropriate consent.
2) Storing or using human tissue donated for a Scheduled Purpose for another purpose.
3) Trafficking in human tissue for transplantation purposes.
4) Carrying out licensable activities without holding a licence from the HTA (with lower penalties for related lesser offences such as failing to produce records or obstructing the HTA in carrying out its power or responsibilities).
5) Having human tissue, including hair, nail, and gametes, with the intention of its DNA being analysed without the consent of the person from whom the tissue came or of those close to them if they have died.
212
key functions of the HTA?
* establish the Human Tissue Authority (HTA) to regulate activities concerning the removal, storage, use and disposal of human tissue
* make appropriate consent a legal requirement for the removal, storage and use of body parts, organs, tissue and cells (“relevant material”). The Human Tissue Act lists the purposes for which consent is required ( these are called “scheduled purposes”)
* introduce licensing requirements for the removal, storage and use of bodies, organs, tissue and cells
* sets out offences and penalties for breaching the requirements
213
arguments for an opt out system?
* increases number of organ donations -> reducing number of patients dying whilst awaiting an organ transplantation
* families are consulted before the donation occurs
* faith and religious beliefs considered
* argued that opt-out systems overcome many traditional barriers to deceased organ donation – such as perceived religious or socio-cultural preclusions, lack of education or transplant awareness and challenges in communicating with families who are grieving a loved one.
214
arguments against an opt out system?
* insufficient consent - explicit consent not sought before the person dies
* unethical - taking away rights of people
* can be seen as a bodily violation
* implies that bodies belong to the state
* safeguaring issues - as patients haven’t directly said they do want their organs to be donated and those that want to refuse could feel pressured by social norms to comply.
215
Principles guiding organ and tissue donation ?
* should be voluntary and altruistic
* free and consented
* respect for donor and receptient autonomy
* confidentiality and protection of donor's and recipients data
216
Ethical issues in organ donation?
* insufficient donors- shortage of obtainable and useable organs
* use of organs from cadavers, infants and organs
* internet and global transplant tourism
* use of organs from living donors - could lead to manipulation, coercion, emotional suffering, morbidity
* financial payments to encourage donation - organs moving from poor to rich
* organ black market
217
Blood donation ethical issues?
* unacceptable for some e.g. Jehovas witnesses
* absolute safety of the blood cannot be guaranteed
* patient rejection of blood transfusions - autonomy
* coercion. financial gain
* anonymity between donor and recipient
218
Discuss the healthcare resource implications of organ transplantation and blood donation
* reduced need for dialysis which is more expensive long term -> reduced health care spending
* lifelong immunosuppressants required - cost
219
Year 3
flashcards
Decks in class (45)
# Cards
-
Clinical Skills256
-
Block 32 Week 172
-
Block 32 Week 2247
-
Block 32 Week 3&4266
-
Block 32 Week 4317
-
Block 32 Week 5274
-
Block 32 Week 7&8291
-
Block 31 Week 1318
-
Block 31 Week 2295
-
Block 31 Week 3232
-
Block 31 Week 4266
-
Block 31 Week 5241
-
Block 31 Week 6238
-
Block 31 Week 7216
-
Block 31 Week 8244
-
Block 31 Pharmacology261
-
Block 31 PPT205
-
Block 31 H&S222
-
Block 32 H&S411
-
Block 32 PPT200
-
Block 33 Week 1254
-
Block 33 Week 2283
-
Block 33 H&S554
-
block 33 week 3201
-
Block 33 Week 4241
-
Block 33 Week 5281
-
Block 33 Week 6243
-
Block 33 Pharmacology149
-
Block 33 Week 7212
-
Block 33 Week 8235
-
Block 33 H&S251
-
Block 34 Week 1237
-
Block 34 Week 2224
-
block 34 week 3270
-
Block 34 Week 4286
-
Block 33 PPT334
-
Block 32 Pharm190
-
Block 34 Week 5252
-
Block 34 Week 6279
-
Block 34 H&S384
-
Block 34 Week 8345
-
Block 34 Week 7262
-
Block 34 PPT319
-
Block 34 Pharm381
-
Block 32 Week 8287
